OncoCipher Curated Oncology Reference & Clinical Trial Directory
Explore 248 source-cited FDA-label and guideline option categories and 970 typed recruiting clinical trials across 5 major solid-tumor indications—available to patients in plain language and to personal AI assistants via native MCP (https://patient.oncocipher.com/mcp).
Breast Cancer
Biomarker-guided reference covering hormone receptor (ER/PR), HER2 / HER2-low IHC/ISH, BRCA1/2, PIK3CA, AKT1/PTEN, ESR1, and recruiting clinical trials.
64 Unranked Reference Options 43 Recruiting Trials
Non-Small Cell Lung Cancer (NSCLC)
Molecularly stratified reference covering EGFR, ALK, ROS1, BRAF V600E, KRAS G12C, MET exon 14, RET, HER2, NTRK, PD-L1 expression, and recruiting trials.
92 Unranked Reference Options 46 Recruiting Trials
Colorectal Cancer (CRC)
Source-cited reference covering MMR/MSI status, KRAS/NRAS, BRAF V600E, HER2 amplification, sidedness, surgical/systemic settings, and recruiting trials.
34 Unranked Reference Options 507 Recruiting Trials
Ovarian, Fallopian Tube & Primary Peritoneal Cancer
Source-cited reference covering germline/somatic BRCA1/2, HRD status, Folate Receptor-alpha (FRa), platinum interval, maintenance categories, and recruiting trials.
22 Unranked Reference Options 342 Recruiting Trials
Cutaneous & Mucosal Melanoma
Source-cited reference covering BRAF V600 status, NRAS/KIT, nodal staging, neoadjuvant/adjuvant and checkpoint/targeted therapy categories, and recruiting trials.
36 Unranked Reference Options 32 Recruiting Trials